Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Genprex Inc. (GNPX)

4.28   1.54 (56.2%) 02-14 16:00
Open: 3.15 Pre. Close: 2.74
High: 5.75 Low: 3.15
Volume: 83,976,853 Market Cap: 119M
Genprex, Inc. operates as a clinical stage gene therapy company. It is involved in developing various approaches to treating cancer, based upon a proprietary technology platform, including Oncoprex immunogene therapy for non-small cell lung cancer. Oncoprex that has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells and re-establishes pathways for apoptosis, or programmed cell death in cancer cells; and modulates the immune response against cancer cells, as well as blocks mechanisms that create drug resistance. The company was founded in 2009 and is headquartered in Austin, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.753 - 5.77 5.77 - 5.79
Low: 3.121 - 3.133 3.133 - 3.146
Close: 4.252 - 4.276 4.276 - 4.303

Technical analysis

as of: 2020-02-14 4:29:13 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.72     One year: 7.84
Support: Support1: 2.40    Support2: 0.32
Resistance: Resistance1: 5.75    Resistance2: 6.72
Pivot: 1.76
Moving Average: MA(5): 2.34     MA(20): 1.62
MA(100): 0.67     MA(250): 1.09
MACD: MACD(12,26): 0.53     Signal(9): 0.33
Stochastic oscillator: %K(14,3): 86.90     %D(3): 75.60
RSI: RSI(14): 85.29
52-week: High: 5.75  Low: 0.23  Change(%): 187.8
Average Vol(K): 3-Month: 591816  10-Days: 1467159

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
GNPX has closed above the upper band by 32.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 494.2% wider than normal. The large width of the bands suggest high volatility as compared to GNPX's normal range. The bands have been in this wide range for 18 bars. This is a sign that the current trend might continue.

Headline News

2020-02-11
Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex licenses patented diabetes gene therapy from University of Pittsburgh.

2020-02-03
Genprex to Present at NobleCon16 Investor Conference
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex's CEO will present at the upcoming Noble Capital Market's annual investor conference.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19.27
Shares Float (M) 9.13
% Held by Insiders 38.87
% Held by Institutions 22.10
Shares Short (K) 361
Shares Short P. Month (K)

Stock Financials

EPS -0.753
Book Value (p.s.) 0.220
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -96.7
Return on Equity (ttm) -166.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.607
Qtrly Earnings Growth
Operating Cash Flow (M) -7.26
Levered Free Cash Flow (M) -4.44

Stock Valuations

P/E -5.68
P/E Growth Ratio 0.56
P/BV 19.45
P/S
P/CF -11.36

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.